Jasper Therapeutics Statistics
Total Valuation
JSPR has a market cap or net worth of $343.65 million. The enterprise value is $227.31 million.
| Market Cap | 343.65M |
| Enterprise Value | 227.31M |
Important Dates
The next estimated earnings date is Friday, August 9, 2024, after market close.
| Earnings Date | Aug 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
JSPR has 15.09 million shares outstanding. The number of shares has increased by 51.74% in one year.
| Shares Outstanding | 15.09M |
| Shares Change (YoY) | +51.74% |
| Shares Change (QoQ) | +20.67% |
| Owned by Insiders (%) | 4.99% |
| Owned by Institutions (%) | 88.26% |
| Float | 8.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.03 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.49, with a Debt / Equity ratio of 0.02.
| Current Ratio | 13.49 |
| Quick Ratio | n/a |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -64.60% and return on invested capital (ROIC) is -60.45%.
| Return on Equity (ROE) | -64.60% |
| Return on Assets (ROA) | -56.20% |
| Return on Capital (ROIC) | -60.45% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.42M |
| Employee Count | 45 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +63.89% in the last 52 weeks. The beta is 2.25, so JSPR's price volatility has been higher than the market average.
| Beta (5Y) | 2.25 |
| 52-Week Price Change | +63.89% |
| 50-Day Moving Average | 23.10 |
| 200-Day Moving Average | 15.73 |
| Relative Strength Index (RSI) | 47.67 |
| Average Volume (20 Days) | 184,597 |
Short Selling Information
The latest short interest is 798,203, so 5.29% of the outstanding shares have been sold short.
| Short Interest | 798,203 |
| Short Previous Month | 684,821 |
| Short % of Shares Out | 5.29% |
| Short % of Float | 8.94% |
| Short Ratio (days to cover) | 8.16 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -69.99M |
| Pretax Income | -63.93M |
| Net Income | -63.93M |
| EBITDA | -62.38M |
| EBIT | -63.93M |
| Earnings Per Share (EPS) | -$5.61 |
Balance Sheet
The company has $118.89 million in cash and $2.55 million in debt, giving a net cash position of $116.34 million or $7.71 per share.
| Cash & Cash Equivalents | 118.89M |
| Total Debt | 2.55M |
| Net Cash | 116.34M |
| Net Cash Per Share | $7.71 |
| Equity (Book Value) | 113.23M |
| Book Value Per Share | 7.51 |
| Working Capital | 111.39M |
Cash Flow
In the last 12 months, operating cash flow was -$57.47 million and capital expenditures -$266,000, giving a free cash flow of -$57.73 million.
| Operating Cash Flow | -57.47M |
| Capital Expenditures | -266,000 |
| Free Cash Flow | -57.73M |
| FCF Per Share | -$4.33 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
JSPR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -51.74% |
| Shareholder Yield | -51.74% |
| Earnings Yield | -18.60% |
| FCF Yield | -16.80% |
Analyst Forecast
The average price target for JSPR is $68.00, which is 198.51% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $68.00 |
| Price Target Difference | 198.51% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -12.54% |
Stock Splits
The last stock split was on January 4, 2024. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jan 4, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |